The news out of Switzerland this month is that Applied Pharma Research (APR) is going to be marketing a new migraine drug in Canada and the USA. Well, new in a sense. You may have heard of the NSAID, Cataflam. Cataflam is commonly used for arthritis. Its medicinal ingredient is diclofenac potassium. The migraine drug will [...]
{ 0 comments }


